Stockscreener 앱 받기
0.32
3.19%
0.0099
시간 외 거래:
.31
-0.01
-3.13%
전일 마감가:
$0.3101
열려 있는:
$0.313
하루 거래량:
237.88K
Relative Volume:
0.65
시가총액:
$31.61M
수익:
$1.20M
순이익/손실:
$-5.34M
주가수익비율:
-5.178
EPS:
-0.0618
순현금흐름:
$-6.27M
1주 성능:
+14.29%
1개월 성능:
+13.07%
6개월 성능:
-22.48%
1년 성능:
+10.12%
1일 변동 폭
$0.31
$0.32
1주일 범위
$0.28
$0.32
52주 변동 폭
$0.242
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
명칭
IGC Pharma Inc
전화
301-983-0998
주소
4336 Montgomery Avenue, Bethesda, MD
Compare IGC vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.32 | 30.64M | 1.20M | -5.34M | -6.27M | -0.0618 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
IGC Pharma Inc 주식(IGC)의 최신 뉴스
IGC Advances Patient Enrollment in Alzheimer's Clinical Trial - GuruFocus
IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout - Finviz
IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout (2026-04-14) - Seeking Alpha
What is IGC Pharma Incs valuation compared to sector2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn
IGC Pharma (IGC) price target increased by 10.34% to 4.08 - MSN
New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Idaho Statesman
IGC Pharma Share Price Target and Forecast - Investing.com India
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts - 富途牛牛
IGC Pharma (NYSEAMERICAN:IGC) Given New $5.25 Price Target at Ascendiant Capital Markets - Defense World
Analyst lifts IGC Pharma target to $5.25 as Alzheimer’s trial advances - Stock Titan
IGC Pharma (NYSEAMERICAN:IGC) Shares Up 0.9% – Still a Buy? - Defense World
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease - marketscreener.com
IGC Pharma Expands Clinical Trial with New Site Activation - GuruFocus
Director at IGC Pharma (IGC) receives 170,000 shares from RSUs - Stock Titan
IGC Pharma (IGC) CEO acquires 706,409 shares via equity awards - Stock Titan
IGC Pharma (IGC) director gains 130K shares from RSU conversions - Stock Titan
IGC Pharma (IGC) PFO Claudia Grimaldi exercises RSUs and options for more shares - Stock Titan
IGC.WS (India Globalization Capital) PB Ratio : (As of Apr. 03, 2026) - GuruFocus
How does IGC Pharma Inc perform in inflationary periodsWeekly Gains Report & Technical Buy Zone Confirmations - baoquankhu1.vn
IGC Pharma Launches National Media Partnership to Boost Visibility - The Globe and Mail
IGC Pharma Launches Strategic National Media Partnership with Ne - GuruFocus
Aug Breakouts: Should I trade or invest in IGC Pharma Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Signal Recap: What is IGC Pharma Incs valuation compared to sectorQuarterly Portfolio Review & Comprehensive Market Scan Insights - baoquankhu1.vn
Performance Recap: What is IGC Pharma Incs book value per shareMarket Growth Review & Stock Market Timing Techniques - baoquankhu1.vn
IGC Pharma launches 12-part national media campaign with New to The Street to boost investor awareness - TradingView — Track All Markets
IGC Pharma (NYSE: IGC) inks 12-part New to The Street deal - Stock Titan
Aug Shorts: What is IGC Pharma Incs book value per share2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
IGC Pharma Partners with New to The Street for National Media Campaign - National Today
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - biospace.com
IGC Pharma Launches Strategic National Media Partnership With New to The Street to Expand Investor Awareness - 富途牛牛
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - The Joplin Globe
Macro Review: Is IGC Pharma Inc likely to announce a buybackChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
If You Invested $1,000 in IGC Pharma Inc (IGC) - Stock Titan
Growth Report: Does IGC Pharma Inc stock benefit from AI growthEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Ascendiant Capital maintains IGC Pharma (IGC) buy recommendation - MSN
Fund Flows: Can IGC Pharma Inc ride the EV wave2026 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
India Globalization Capital, Inc.: Fundamental Analysis and Financial Ratings | IGC | US45408X3089 - marketscreener.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Hastings Tribune
IGC Achieves Major Milestone in Alzheimer's Trial Amid Financial Loss - GuruFocus
IGC Pharma’s AI-Driven Innovations and Patent Portfolio for Alzheimer’s Disease and Neuropsychiatric Treatments - Minichart
IGC to Showcase AI Platform for Alzheimer's Research at 2026 Con - GuruFocus
IGC Pharma Inc (IGC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.69%
0.25%
자본화:
|
볼륨(24시간):